GSK Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	32,667	31,376	30,328	29,324	24,696
Revenue Growth (YoY)	4.12%	3.46%	3.42%	18.74%	1.40%
Cost of Revenue	9,017	9,048	8,565	9,554	8,163
Gross Profit	23,650	22,328	21,763	19,770	16,533
Selling, General & Admin	9,088	11,015	9,385	8,372	7,070
Research & Development	7,525	6,401	6,223	5,488	5,019
Other Operating Expenses	-16	1,530	363	235	504
Total Operating Expenses	16,597	18,946	15,971	14,095	12,593
Operating Income	7,932	4,021	6,745	6,433	4,357
Interest Income	169	122	115	76	14
Interest Expense	-701	-669	-792	-879	-769
Other Non-Operating Income (Expense)	1	6	1	-2	-36
Total Non-Operating Income (Expense)	-531	-541	-676	-805	-791
Pretax Income	7,401	3,477	6,064	5,628	3,599
Provision for Income Taxes	1,112	526	756	707	83
Net Income	5,716	2,575	4,928	14,956	4,385
Minority Interest in Earnings	573	376	380	665	711
Earnings From Discontinued Operations	-	-	-	10,700	1,580
Net Income to Common	5,716	2,575	4,928	14,956	4,385
Net Income Growth	121.98%	-47.75%	-67.05%	241.07%	-23.73%
Shares Outstanding (Basic)	2,026	2,039	2,026	2,013	2,002
Shares Outstanding (Diluted)	2,059	2,071	2,056	2,042	2,026
Shares Change (YoY)	-0.60%	0.75%	0.66%	0.79%	0.55%
EPS (Basic)	2.82	1.26	2.43	7.43	2.19
EPS (Diluted)	2.78	1.24	2.40	7.32	2.16
EPS Growth	123.15%	-48.12%	-67.26%	238.45%	-24.12%
Shares Outstanding	2,007	2,041	2,058	2,156	2,155
Free Cash Flow	6,393	5,155	5,454	6,260	7,002
Free Cash Flow Growth	24.02%	-5.48%	-12.88%	-10.60%	-6.04%
Free Cash Flow Per Share	3.11	2.49	2.65	3.07	3.46
Dividends Per Share	0.660	0.610	0.580	0.613	1.000
Dividend Growth	8.20%	5.17%	-5.31%	-38.75%	-
Gross Margin	72.40%	71.16%	71.76%	67.42%	66.95%
Operating Margin	24.28%	12.82%	22.24%	21.94%	17.64%
Profit Margin	19.25%	9.41%	17.50%	53.27%	20.63%
FCF Margin	19.57%	16.43%	17.98%	21.35%	28.35%
EBITDA	10,246	6,572	9,039	8,580	6,479
EBITDA Margin	31.36%	20.95%	29.80%	29.26%	26.24%
EBIT	7,932	4,021	6,745	6,433	4,357
EBIT Margin	24.28%	12.82%	22.24%	21.94%	17.64%
Effective Tax Rate	15.02%	15.13%	12.47%	12.56%	2.31%

Updated Feb 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q